hengrui – Lab DB

Pharmaceutical R&D

Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration

Teuku Ryan May 13, 2026 0

Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…

Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration

YOU MAY HAVE MISSED

Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies

Pioneering Sequencing by Synthesis: David Klenerman Reflects on a Decade of Innovation and the Future of Biotech

Diabetes to MASH: the specimens behind GLP-1’s widening roster

Seven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain